Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11490180rdf:typepubmed:Citationlld:pubmed
pubmed-article:11490180lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:11490180lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:11490180lifeskim:mentionsumls-concept:C0000530lld:lifeskim
pubmed-article:11490180lifeskim:mentionsumls-concept:C0009079lld:lifeskim
pubmed-article:11490180lifeskim:mentionsumls-concept:C0018546lld:lifeskim
pubmed-article:11490180lifeskim:mentionsumls-concept:C0442805lld:lifeskim
pubmed-article:11490180lifeskim:mentionsumls-concept:C1149915lld:lifeskim
pubmed-article:11490180lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:11490180pubmed:issue2lld:pubmed
pubmed-article:11490180pubmed:dateCreated2001-8-7lld:pubmed
pubmed-article:11490180pubmed:abstractTextIn the search for differential mechanisms underlying clozapine's superior antipsychotic efficacy, the purinergic system has been considered, since an antagonist of the adenosine receptor A(2A) was shown to block clozapine acute effects on c-fos expression in rat striatum. Further investigating the interaction of clozapine with the purinergic system, we studied the effects of chronic treatment (28 days, intraperitoneal) with clozapine (25 mg/kg) and haloperidol (1.5 mg/kg) on the activity of ectonucleotidases in the striatum and hippocampus of rats. Clozapine selectively increased striatal 5'-nucleotidase activity (22%) compared to control and haloperidol groups. In vitro, neither drug affected enzyme activities. These results reinforce the differential effects of clozapine compared to haloperidol on the purinergic system.lld:pubmed
pubmed-article:11490180pubmed:languageenglld:pubmed
pubmed-article:11490180pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11490180pubmed:citationSubsetIMlld:pubmed
pubmed-article:11490180pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11490180pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11490180pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11490180pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11490180pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11490180pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11490180pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11490180pubmed:statusMEDLINElld:pubmed
pubmed-article:11490180pubmed:issn0302-282Xlld:pubmed
pubmed-article:11490180pubmed:authorpubmed-author:QuevedoJJlld:pubmed
pubmed-article:11490180pubmed:authorpubmed-author:SarkisJ JJJlld:pubmed
pubmed-article:11490180pubmed:authorpubmed-author:SouzaD ODOlld:pubmed
pubmed-article:11490180pubmed:authorpubmed-author:ViannaM RMRlld:pubmed
pubmed-article:11490180pubmed:authorpubmed-author:BattastiniA...lld:pubmed
pubmed-article:11490180pubmed:authorpubmed-author:LaraD RDRlld:pubmed
pubmed-article:11490180pubmed:authorpubmed-author:de ParisFFlld:pubmed
pubmed-article:11490180pubmed:authorpubmed-author:OsesJ PJPlld:pubmed
pubmed-article:11490180pubmed:copyrightInfoCopyright 2001 S. Karger AG, Basellld:pubmed
pubmed-article:11490180pubmed:issnTypePrintlld:pubmed
pubmed-article:11490180pubmed:volume44lld:pubmed
pubmed-article:11490180pubmed:ownerNLMlld:pubmed
pubmed-article:11490180pubmed:authorsCompleteYlld:pubmed
pubmed-article:11490180pubmed:pagination99-102lld:pubmed
pubmed-article:11490180pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11490180pubmed:meshHeadingpubmed-meshheading:11490180...lld:pubmed
pubmed-article:11490180pubmed:meshHeadingpubmed-meshheading:11490180...lld:pubmed
pubmed-article:11490180pubmed:meshHeadingpubmed-meshheading:11490180...lld:pubmed
pubmed-article:11490180pubmed:meshHeadingpubmed-meshheading:11490180...lld:pubmed
pubmed-article:11490180pubmed:meshHeadingpubmed-meshheading:11490180...lld:pubmed
pubmed-article:11490180pubmed:meshHeadingpubmed-meshheading:11490180...lld:pubmed
pubmed-article:11490180pubmed:meshHeadingpubmed-meshheading:11490180...lld:pubmed
pubmed-article:11490180pubmed:meshHeadingpubmed-meshheading:11490180...lld:pubmed
pubmed-article:11490180pubmed:meshHeadingpubmed-meshheading:11490180...lld:pubmed
pubmed-article:11490180pubmed:meshHeadingpubmed-meshheading:11490180...lld:pubmed
pubmed-article:11490180pubmed:meshHeadingpubmed-meshheading:11490180...lld:pubmed
pubmed-article:11490180pubmed:meshHeadingpubmed-meshheading:11490180...lld:pubmed
pubmed-article:11490180pubmed:meshHeadingpubmed-meshheading:11490180...lld:pubmed
pubmed-article:11490180pubmed:meshHeadingpubmed-meshheading:11490180...lld:pubmed
pubmed-article:11490180pubmed:meshHeadingpubmed-meshheading:11490180...lld:pubmed
pubmed-article:11490180pubmed:year2001lld:pubmed
pubmed-article:11490180pubmed:articleTitleChronic treatment with clozapine, but not haloperidol, increases striatal ecto-5'-nucleotidase activity in rats.lld:pubmed
pubmed-article:11490180pubmed:affiliationDepartment of Biochemistry, Institute of Health Basic Science, UFRGS, Porto Alegre, Brazil. drlara@plug-in.com.brlld:pubmed
pubmed-article:11490180pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11490180pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:11490180pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11490180lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11490180lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11490180lld:pubmed